FDA Inspection 1337230 — Sterling Institutional Review Board

Sterling Institutional Review Board — FEI 1000219675

The FDA completed an inspection of Sterling Institutional Review Board on Sep 17, 2026 in Atlanta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Sep 17, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Atlanta, GA (United States)

Additional details

IRB

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.